View : 64 Download: 0

Fine-tuning the electronic structure of heavy-atom-freeBODIPYphotosensitizers for fluorescence imaging and mitochondria-targeted photodynamic therapy

Title
Fine-tuning the electronic structure of heavy-atom-freeBODIPYphotosensitizers for fluorescence imaging and mitochondria-targeted photodynamic therapy
Authors
Qi, SujieKwon, NahyunYim, YubinVan-Nghia NguyenYoon, Juyoung
Ewha Authors
윤주영
SCOPUS Author ID
윤주영scopus
Issue Date
2020
Journal Title
CHEMICAL SCIENCE
ISSN
2041-6520JCR Link

2041-6539JCR Link
Citation
CHEMICAL SCIENCE vol. 11, no. 25, pp. 6479 - 6484
Publisher
ROYAL SOC CHEMISTRY
Indexed
SCIE; SCOPUS WOS scopus
Document Type
Article
Abstract
Theranostics that combines both diagnosis and therapy into a single platform has recently emerged as a promising biomedical approach for cancer treatment; however, the development of efficient theranostic agents with excellent optical properties remains a challenge. Here, we report novel mitochondria-targetingBODIPYphotosensitizers (R-BODs) that possess considerable singlet oxygen generation capabilities and good fluorescence properties for imaging-guided photodynamic therapy (PDT). The incorporation of sulfur atoms into the pi-conjugated skeleton ofBODIPYalong with the introduction of different functional groups at themeso-position of theBODIPYcore is essential for tuning the photophysical and photosensitizing properties. Notably, the MeOPh-substituted thiophene-fusedBODIPY(MeO-BOD, R =p-methoxyphenyl) displayed the highest singlet oxygen generation capability (phi(Delta)approximate to 0.85 in air-saturated acetonitrile) and a moderate fluorescence quantum yield (phi(f)= 17.11). Furthermore,MeO-BODshowed good biocompatibility, low dark toxicity and superior fluorescence imaging properties in living cells. More importantly, the PDT efficacy of mitochondria-specific anchoring ofMeO-BODwas remarkably amplified with an extremely low half-maximal inhibitory concentration (IC50) value of 95 nM. We believe that the incorporation of an electron-donating group at themeso-position of the thiophene-fusedBODIPYplatform may be an effective approach for developing theranostic agents for precision cancer therapy.
DOI
10.1039/d0sc01171a
Appears in Collections:
자연과학대학 > 화학·나노과학전공 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE